Clinical Trials Directory

Trials / Completed

CompletedNCT02149238

Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects

Acute Study to Investigate the Interaction of Cocoa Methylxanthines With Cocoa Flavanol Related Vascular Effects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Heinrich-Heine University, Duesseldorf · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Epidemiological studies suggest that certain foods rich in flavanols, including cocoa products, red wine, and tea, are associated with decreased cardiovascular mortality and morbidity. Dietary interventional studies have corroborated this finding and showed that flavanols can acutely and after sustained ingestion improve surrogate markers of cardiovascular risk including endothelial function. Endothelial dysfunction is the key event in the development and progression of cardiovascular disease. Aging is the major non-modifiable cardiovascular risk factor associated with progressive decline in endothelial function, vascular stiffening and increase in blood pressure. However, in addition to flavanols, other potentially bioactive compounds are present in cocoa, in particular methylxanthines. Little is known about the vascular effects of cocoa methylxanthines, i.e. mainly theobromine, in particular when consumed together with flavanols in cocoa products. The aim of the study is to characterize the nutrient-nutrient interaction between cocoa flavanols and cocoa methylxanthines.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTflavanol
DIETARY_SUPPLEMENTmethylxanthine
DIETARY_SUPPLEMENTflavanol + methylxanthine

Timeline

Start date
2011-02-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-05-29
Last updated
2014-12-23

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02149238. Inclusion in this directory is not an endorsement.